Process for Synthesis of (3R,3'R,6'R)-Lutein and its Stereoisomers
AssigneeUniversity of Maryland, College Park
InventorsFrederick Khachik, An-Ni Chang
Life of this patent
Estimating the term…
Loading patent…
AssigneeUniversity of Maryland, College Park
InventorsFrederick Khachik, An-Ni Chang
Estimating the term…
(3R,3′R,6′R)-Lutein and (3R,3′R)-zeaxanthin are two dietary carotenoids that are present in most fruits and vegetables commonly consumed in the US. These carotenoids accumulate in the human plasma, major organs, and ocular tissues. In the past decade, numerous epidemiological and experimental studies have shown that lutein and zeaxanthin play an important role in the prevention of age-related macular degeneration (AMD) that is the leading cause of blindness in the U.S. and Western World. The invention provides a process for the synthesis of (3R,3′R,6′R)-lutein and its stereoisomers from commercially available (rac)-α-ionone by a C15+C10+C15 coupling strategy. In addition, the present invention also provides access to the precursors of optically active carotenoids with 3-hydroxy-ε-end group that are otherwise difficult to synthesize. The process developed for the synthesis of lutein and its stereoisomers is straightforward and has potential for commercialization.
A method for synthesis of a compound having the Formula (I):
A method comprising reacting (rac)-α-ionone with an oxidizing agent to obtain (rac)-3-keto-α-ionone.
A method of preparing (3R,6R)-3-hydroxy-13-apo-ε-caroten-13-one (27) and (3R)-3-hydroxy-13-apo-β-caroten-13-one (28) comprising oxidatively degrading (3R,3′R,6′R)-lutein diacetate with tert-BuOOH (TBHP) and bleach, at a temperature ranging from −5° C. to room temperature (R.T.), in a solvent selected from the group consisting of acetonitrile (CH3CN), methylene chloride (CH2Cl2), ethyl acetate, hexane, tetrahydrofuran (THF), tert-butyl methyl ether (TBME), dimethylformamide (DMF), dimethylsulfoxide (DMSO), a straight chain C1-C5 alcohol and a branched C1-C5 alcohol to obtain (3R,6R)-3-hydroxy-13-apo-ε-caroten-13-one (27) and (3R)-3-hydroxy-13-apo-β-caroten-13-one (28).
A method of preparing a compound of the Formula XII and a compound of the Formula XIII comprising oxidatively degrading a compound having the Formula XI:
Dependencies are inferred from the claim text.